INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 211 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,871,690 | -16.4% | 1,381,057 | -30.2% | 0.57% | -19.3% |
| Q2 2023 | $41,720,819 | +23.7% | 1,977,290 | -0.0% | 0.71% | +15.4% |
| Q1 2023 | $33,717,329 | -12.9% | 1,977,556 | +2.0% | 0.61% | -19.3% |
| Q4 2022 | $38,727,133 | +51.5% | 1,938,295 | +63.3% | 0.76% | +59.6% |
| Q3 2022 | $25,566,000 | +15.9% | 1,186,867 | +6.1% | 0.48% | +7.7% |
| Q2 2022 | $22,061,000 | -12.0% | 1,118,673 | +4.9% | 0.44% | +22.2% |
| Q1 2022 | $25,070,000 | -29.6% | 1,066,761 | -18.4% | 0.36% | -26.5% |
| Q4 2021 | $35,603,000 | +2.3% | 1,306,992 | +3.5% | 0.49% | +5.4% |
| Q3 2021 | $34,794,000 | +1.0% | 1,263,403 | +4.4% | 0.47% | -7.7% |
| Q2 2021 | $34,457,000 | +81.3% | 1,210,714 | +116.9% | 0.50% | +92.7% |
| Q1 2021 | $19,010,000 | -17.3% | 558,135 | -19.2% | 0.26% | -20.4% |
| Q4 2020 | $22,984,000 | – | 690,411 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |